N. Anderson
Direktor/Vorstandsmitglied bei LUNA INNOVATIONS INCORPORATED
Vermögen: 32 304 $ am 30.04.2024
Aktive Positionen von N. Anderson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LUNA INNOVATIONS INCORPORATED | Direktor/Vorstandsmitglied | 24.05.2017 | - |
Independent Dir/Board Member | 24.05.2017 | - | |
The Plasma Proteome Institute | Vorstandsvorsitzender | 01.01.2002 | - |
Gründer | 01.01.2002 | - | |
Anderson Forschung Group LLC | Corporate Officer/Principal | 01.01.2002 | - |
Direktor/Vorstandsmitglied | 01.01.2002 | 23.05.2011 | |
Siscapa Assay Technologies, Inc.
Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Vorstandsvorsitzender | 01.01.2011 | - |
Gründer | 01.01.2011 | - |
Karriereverlauf von N. Anderson
Ehemalige bekannte Positionen von N. Anderson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Dade Behring Holdings, Inc.
Dade Behring Holdings, Inc. Medical SpecialtiesHealth Technology Dade Behring Holdings, Inc. manufactures medical diagnostic equipment. It develops and markets equipment and consumable supplies and provides maintenance services to clinical laboratories to perform diagnostic tests. The company's customers include hospitals and reference laboratories. The company was founded in 1994 and is headquartered in Deerfield, IL. | Direktor/Vorstandsmitglied | 01.01.2002 | 01.01.2007 |
Large Scale Biology Corp.
Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | 01.01.2002 |
Gründer | 01.01.2001 | 01.01.2002 |
Ausbildung von N. Anderson
University of Cambridge | Doctorate Degree |
Yale University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 3 |
Founder | 3 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LUNA INNOVATIONS INCORPORATED | Electronic Technology |
Private Unternehmen | 5 |
---|---|
Large Scale Biology Corp.
Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Health Technology |
Dade Behring Holdings, Inc.
Dade Behring Holdings, Inc. Medical SpecialtiesHealth Technology Dade Behring Holdings, Inc. manufactures medical diagnostic equipment. It develops and markets equipment and consumable supplies and provides maintenance services to clinical laboratories to perform diagnostic tests. The company's customers include hospitals and reference laboratories. The company was founded in 1994 and is headquartered in Deerfield, IL. | Health Technology |
Siscapa Assay Technologies, Inc.
Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Health Technology |
The Plasma Proteome Institute | |
Anderson Forschung Group LLC |
- Börse
- Insiders
- N. Anderson
- Erfahrung